Quick Answer
BioRestorative Therapies, Inc. reported Net Income Loss of -$14.24 million for the year ending 2025.
- BioRestorative Therapies, Inc. showed a decrease of -58.6% in Net Income Loss from 2024 to 2025.
- This data is from BioRestorative Therapies, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: -$14.24 million | Fiscal year 2024: -$8.98 million | Fiscal year 2023: -$10.42 million | Fiscal year 2022: -$18.49 million | Fiscal year 2021: -$44.30 million | Fiscal year 2020: -$11.27 million | Fiscal year 2019: -$14.65 million | Fiscal year 2018: -$12.52 million | Fiscal year 2017: -$9.44 million | Fiscal year 2016: -$8.64 million | Fiscal year 2015: -$7.92 million | Fiscal year 2014: -$5.59 million | Fiscal year 2013: -$5.75 million | Fiscal year 2012: -$6.54 million | Fiscal year 2011: -$4.07 million | Fiscal year 2010: -$2.26 million | Fiscal year 2009: -$1.20 million | Fiscal year 2008: $0.00.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: